XClose

UCL Enterprise

Home
Menu

Spirogen sold to AstraZeneca

16 October 2013

AstraZeneca to pay $440m for UK biotech business
Pharmaceutical group makes acquisition in oncology group spun out of university
Read: Guardian

AstraZeneca Buys Spirogen for $440 Million
MedImmune Unit Also Enters Deal with ADC Therapeutics
Read: Wall Street Journal